Report overview
Rosuvastatin calcium (CAS 147098-20-2, molecular formula being C44H54CaF2N6O12S2) is the active pharmaceutical ingredient for the once-a-day dyslipidaemia treatment Crestor, it is one approved API which can be used to reduce the risk of heart attack and stroke.Rosuvastatin calcium is a hygroscopic powder suitable for the manufacture of tablets and capsules. The appropriate excipients need to be added. The particle size of the product is designed in such a way that optimal dissolution can be obtained (depending on formulation).
Rosuvastatin Calcium is a member of the drug class of statins, used in combination with exercise, diet, and weight-loss to treat high cholesterol and related conditions, and to prevent cardiovascular disease. It works by slowing the production of cholesterol in the body to decrease the amount of cholesterol that may build up on the walls of the arteries and block blood flow to the heart, brain, and other parts of the body. Rosuvastatin Calcium was developed by Shionogi and has been formulated into finished oral dosage form and marketedby AstraZeneca as Crestor, Abbott Laboratories as R2.
This report aims to provide a comprehensive presentation of the global market for Rosuvastatin Calcium, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rosuvastatin Calcium. This report contains market size and forecasts of Rosuvastatin Calcium in global, including the following market information:
Global Rosuvastatin Calcium Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Rosuvastatin Calcium Market Sales, 2018-2023, 2024-2029, (Kg)
Global top five Rosuvastatin Calcium companies in 2022 (%)
The global Rosuvastatin Calcium market was valued at US$ 540.9 million in 2022 and is projected to reach US$ 703.6 million by 2029, at a CAGR of 3.8% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
In additional, EU is also the largest consumer of rosuvastatin calcium, about 34% of the global production was consumed in EU. China is the second producer with the market share of 28%. Top Three manufacturers in rosuvastatin calcium are AstraZeneca, MSN Laboratories, Changzhou Pharmaceutical Factory, according for 55% of the total amount.
We surveyed the Rosuvastatin Calcium manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Rosuvastatin Calcium Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (Kg)
Global Rosuvastatin Calcium Market Segment Percentages, by Type, 2022 (%)
Purity 98.0%
Purity 99.0%
Other
Global Rosuvastatin Calcium Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (Kg)
Global Rosuvastatin Calcium Market Segment Percentages, by Application, 2022 (%)
Tablet (including dispersible tablet and general tablet)
Capsule
Others
Global Rosuvastatin Calcium Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (Kg)
Global Rosuvastatin Calcium Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Rosuvastatin Calcium revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Rosuvastatin Calcium revenues share in global market, 2022 (%)
Key companies Rosuvastatin Calcium sales in global market, 2018-2023 (Estimated), (Kg)
Key companies Rosuvastatin Calcium sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
AstraZeneca
Teva Pharmaceutical Industries
MSN Laboratories
Cadila Pharmaceuticals
LGM Pharma
Bal Pharma
Changzhou Pharmaceutical Factory
Jingxin Pharm
Zhejiang Hisun Pharmaceutical
HEC Pharm
Lunan Pharmaceutical
Nanjing Frochem Tech
Lianyungang Runzhong Pharmaceutical
Shandong Bechem Chemicals
CTX Life Sciences
Outline of Major Chapters:
Chapter 1: Introduces the definition of Rosuvastatin Calcium, market overview.
Chapter 2: Global Rosuvastatin Calcium market size in revenue and volume.
Chapter 3: Detailed analysis of Rosuvastatin Calcium manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Rosuvastatin Calcium in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Rosuvastatin Calcium capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
